Circulation

Vol. 152, Issue 5 Issue 5 2025
9
Articles

Articles in this Issue

Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation Receiving Oral Antiplatelet Therapy: Definitely Safe, but How Effective?

Philippe Gabriel Steg, Jules Mesnier Aug 05, 2025 pp. 297-299 10.1161/circulationaha.125.075816

Letter by Jha Regarding Article, “Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial”

Ajay Kumar Jha Aug 05, 2025 10.1161/circulationaha.124.073668

Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial

Samer Al Said, Siddharth M. Patel, Robert P. Giugliano et al. Aug 05, 2025 pp. 290-296 10.1161/circulationaha.125.074037

BACKGROUND: Combining antiplatelet therapy (APT) with conventional anticoagulants increases the risk of bleeding. In the AZALEA-TIMI 71 trial (Safety and Tolerability of Abelacimab [MAA868...

Exercise Intolerance and Response to Training in Patients With Postacute Sequelae of SARS-CoV2 (Long COVID): A Scientific Statement From the American Heart Association

William K. Cornwell, Benjamin D. Levine, Diane Baptiste et al. Aug 05, 2025 10.1161/cir.0000000000001348

The postacute sequelae of SARS-CoV-2, also known as Long COVID, may affect 10% to 25% of individuals diagnosed with SARS-CoV-2. More than 100 symptoms have been reported among patients with Long COVID...

The Impact of Coronary Artery Disease in Patients With Peripheral Artery Disease Undergoing Lower-Extremity Revascularization for Chronic Limb-Threatening Ischemia

Joshua A. Beckman, Alain T. Drooz, Alik Farber et al. Aug 05, 2025 pp. 346-348 10.1161/circulationaha.124.072241

METTL3 Is Essential for Exercise Benefits in Diabetic Cardiomyopathy

Chunyan Wang, Siman Shen, Jiayi Kang et al. Aug 05, 2025 pp. 327-345 10.1161/circulationaha.124.070279

BACKGROUND: Exercise improves functional outcomes in patients with diabetic cardiomyopathy (DiaCM). The molecular mechanism underlying cardiac benefits of exercise in DiaCM remains incompl...

Family Screening in Relatives at Risk for Plakophilin-2–Associated Arrhythmogenic Right Ventricular Cardiomyopathy

Steven A. Muller, Babken Asatryan, Alessio Gasperetti et al. Aug 05, 2025 pp. 313-326 10.1161/circulationaha.125.074058

BACKGROUND: Penetrance and risk of ventricular arrhythmias (VAs) in arrhythmogenic right ventricular cardiomyopathy (ARVC) are increasingly recognized as bei...

Aortic Aneurysm Risk and the Somatic <i>JAK2</i> <sup> <i>V617F</i> </sup> Mutation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study

Lasse M. Obel, Joachim S. Skovbo, Axel C.P. Diederichsen et al. Aug 05, 2025 pp. 300-312 10.1161/circulationaha.125.074002

BACKGROUND: The somatic JAK2 V617F sequence variation, a key driver of myeloproliferative neoplasms...

Two Sides of a Coin: Safety Versus Harm of the ACC/AHA Perioperative Guideline Class 1 Level C-LD Recommendation for SGLT Discontinuation

Conrad J. Macon, Christopher Chien, Joaquin E. Cigarroa Aug 05, 2025 pp. 287-289 10.1161/circulationaha.125.072732

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page